Adapting Enhanced Recovery After Surgery (ERAS) protocols to the ambulatory surgery setting is an ongoing need. While all surgical procedures necessitate the need for recovery protocols, urologists looking to perform outpatient surgical oncology procedures must be cognizant of the restrictive discharge criteria for an ambulatory procedure. Furthermore, a surgery being performed in the ambulatory setting should not imply that the procedure is without the risk of morbidity. With this in mind, ERAS protocols are paramount to ensuring optimal surgical outcomes. The individual components of such protocols encompass the perioperative period in its entirety. They include patient education, the stabilization of chronic medical conditions, perioperative nutrition, frailty mitigation, and the management of various postoperative sequalae. This review paper evaluates and summarizes the essential role of pharmacotherapy in ERAS protocols for ambulatory urologic oncology surgery.
将加速康复外科(ERAS)方案应用于日间手术环境是一项持续的需求。尽管所有外科手术都需要康复方案,但计划开展门诊肿瘤外科手术的泌尿科医生必须明确日间手术严格的出院标准。此外,在日间环境中进行的手术并不意味着没有发病风险。有鉴于此,ERAS方案对于确保最佳手术效果至关重要。此类方案的各个组成部分涵盖了整个围手术期,包括患者教育、慢性病情的稳定、围手术期营养、衰弱状态的改善以及各种术后后遗症的管理。本综述评估并总结了药物治疗在日间泌尿肿瘤外科ERAS方案中的核心作用。